Mandate

Vinge advises Agnico Eagle in connection with its acquisition of a majority stake in and joint venture regarding Gunnarn Mining AB

June 18, 2015 M&A

Vinge advises Agnico Eagle Mines Limited in connection with its acquisition of a 55% interest in Gunnarn Mining AB, the owner of the Barsele Gold Project, from Orex Minerals Inc. for US $10 million and the entering into of a joint venture agreement for the management and operation of Gunnarn Mining AB and the exploration and development of the Barsele project. As part of the transaction, Agnico Eagle granted a royalty interest in the project to Orex, has committed to spend US $7 million over three years and will earn an additional 15% interest in Gunnarn Mining AB if it completes a pre-feasibility study. The transaction was completed on 11 June 2015.

Vinge advises Agnico Eagle on Swedish law matters and in co-operation with Davies Ward Phillips & Vineberg LLP. Vinge’s team consists of M&A partners Malin Ohlin and Peter Sundgren, associates Kajsa Hallner (M&A), Isabell Nielsen (commercial agreements), Lova Unge (employment and benefits), Tora Hansjons (tax) and counsels Maria Schultzberg (tax) and Johan Cederblad (real estate and environment).

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025